MEDICAL TECHNOLOGY
Untitled Page
Agendia launches TargetPrint
Huntington Beach- and Amsterdam-based Agendia has released a new test to determine accurate breast cancer treatment.
By Ashley EliotPublished: September 05, 2008 12:46 PM
Breast cancer is a leading cause of death in women, but there's hope ahead. Agendia, also known as the Decoding Center (decoding cancer is the company's mission) is expanding its horizons with the TargetPrint technology. It predicts breast cancer tumor levels for better treatment of patients.
The diagnostic test indicates what treatments will most likely benefit breast cancer patients. Health care professionals, with Agendia's help, will be able to diagnose breast cancer much faster.
Clinical data on TargetPrint will be discussed at the 2008 Breast Cancer Symposium in Washington, D.C., this weekend, Sept. The event is co-sponsored by the American Society of Clinical Oncology (ASCO).
To find out more, go to agendia.com.
|
||||
|
The diagnostic test indicates what treatments will most likely benefit breast cancer patients. Health care professionals, with Agendia's help, will be able to diagnose breast cancer much faster. Clinical data on TargetPrint will be discussed at the 2008 Breast Cancer Symposium in Washington, D.C., this weekend, Sept. The event is co-sponsored by the American Society of Clinical Oncology (ASCO). To find out more, go to agendia.com. |
||||
Digg This Article
